Kanova Biopharma Secures Over RMB 100 Million in Financing for Autoimmune and Oncology Pipeline
Kanova Biopharma, a Suzhou-based developer of antibodies focused on autoimmune diseases and oncology, has reportedly...
Finance
Carbon Medical Technology Secures Over RMB 100 Million in Series A Financing for Interventional Therapy
Shenzhen-based Carbon Medical Technology Co., Ltd has reportedly raised over RMB 100 million (USD 13.9...
Zennova Pharmaceutical Group Secures RMB 100 Million in Series B Financing for Commercial Manufacturing and R&D
China-based Zennova Pharmaceutical Group has reportedly raised close to RMB 100 million (USD 13.9 million)...
Boyu Capital Acquires Hong Kong Medical Device Company Quasar for Over $600 Million
Boyu Capital, according to a Bloomberg report, is set to acquire Quasar, a Hong Kong-based...
Novartis Q2 2023 Results Exceed Expectations with 9% YOY Sales Growth
Swiss pharmaceutical major Novartis AG (NYSE: NVS) has reported its financial results for the second...
MindRank Ltd Secures Over $20 Million in Series A+ Funding to Advance AI Drug Development
China-based artificial intelligence (AI)-enabled drug developer MindRank Ltd has reportedly secured more than USD 20...
Novartis Acquires DTx Pharma and Its FALCON Technology for Up to $1 Billion
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced the acquisition of DTx Pharma Inc., a...
Puncture Robotic Secures $13.9 Million in Series A+ Funding to Advance Medical Robotics
Puncture Robotic, a Shanghai-based developer of medical robots, has reportedly raised RMB 100 million (USD...
Sensview Secures Tens of Millions in Series A+ Funding for X-Ray Detector Tech
Sensview, a developer of solid-state imaging chips and detector module products based in Chengdu, has...
Nanjing Enrui Kainuo Biotechnology Secures Pre-Series A Funding for Cell Therapy Development
Nanjing Enrui Kainuo Biotechnology Co., Ltd, a China-based cell therapy developer, has reportedly raised tens...
Pyrotech (Beijing) Biotechnology Secures $97.37 Million in Series A Financing
China-based biotech firm Pyrotech (Beijing) Biotechnology Co., Ltd announced the successful completion of a CNY...
Shanghai Xinhengrui Medical Technology Secures Series A Funding for Heart Failure Device Development
Shanghai Xinhengrui Medical Technology Co., Ltd, a manufacturer of heart failure devices, has successfully raised...
Beyond Therapeutics Secures Tens of Millions in Pre-Series A Financing for Ophthalmology and Oncology Pipeline
Beyond Therapeutics Co., Ltd., a biotechnology company based in Suzhou with a focus on ophthalmology...
Centre Medical Secures Tens of Millions in Series A Financing to Expand Globally
Centre Medical, a Hong Kong-based cardiovascular specialized medical services provider, has reportedly raised tens of...
Guangdong’s OptoMedic Secures Over $27.8 Million in Pre-IPO Financing for Endoscopy Innovations
OptoMedic Technologies, Inc., a leading endoscopy specialist based in Guangdong, has reportedly raised upwards of...
Sinopep-Allsino Bio Pharmaceutical Cuts Fundraising Target to RMB434 Million via Convertible Bonds”
Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd has revised its proposal...
Jacobio Pharma Secures RMB 150 Million Investment to Advance Pipeline Programs
China-based Jacobio Pharma (HKG: 1167) has announced receiving RMB 150 million (USD 20.7 million) in...
ChengDu ShengNuo Biotechnology Aims to Raise RMB 160 Million for Peptide Drug CDMO Expansion
China-based ChengDu Shengnuo Biotechnology Co., Ltd., (SHA: 688117) has announced plans to raise up to...
Brii Biosciences Expands Collaboration with VBI Vaccines on Hepatitis B Virus Therapies
China-based Brii Biosciences Ltd (HKG: 2137) has announced an expanded license agreement with US firm...